These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 2844050)

  • 1. [Establishment and characterization of EBNA-negative, EBV-genome DNA-positive B cell lines].
    Nakano M; Toyama K; Niizuma M; Hayata Y
    Nihon Ketsueki Gakkai Zasshi; 1988 May; 51(3):596-605. PubMed ID: 2844050
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of Epstein-Barr virus nuclear antigen(s) in different cell lines by radioimmunoelectrophoresis.
    Sculley TB; Spelsberg TC; Pearson GR
    Intervirology; 1984; 22(4):191-200. PubMed ID: 6096291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis.
    Gregory CD; Dive C; Henderson S; Smith CA; Williams GT; Gordon J; Rickinson AB
    Nature; 1991 Feb; 349(6310):612-4. PubMed ID: 1705663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient expression of the Epstein-Barr virus LMP1 gene in human primary B cells induces cellular activation and DNA synthesis.
    Peng M; Lundgren E
    Oncogene; 1992 Sep; 7(9):1775-82. PubMed ID: 1354347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and biochemical evidence that EBNA 2 interaction with a 63-kDa cellular GTG-binding protein is essential for B lymphocyte growth transformation by EBV.
    Yalamanchili R; Tong X; Grossman S; Johannsen E; Mosialos G; Kieff E
    Virology; 1994 Nov; 204(2):634-41. PubMed ID: 7941331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.
    Nilsson T; Sjöblom A; Masucci MG; Rymo L
    Virology; 1993 Apr; 193(2):774-85. PubMed ID: 8384755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and differentiation of Epstein-Barr virus strains by in situ polymerase chain reaction.
    Tamaki H; Byron KS; Sullivan JL; Somasundaran M
    Mol Cell Probes; 1997 Jun; 11(3):237-41. PubMed ID: 9232625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immortalization of human lymphocytes by Epstein-Barr virus.
    Miller G
    Yale J Biol Med; 1982; 55(3-4):305-10. PubMed ID: 6295007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus and human chromosomes: close association of the resident viral genome and the expression of the virus-determined nuclear antigen (EBNA) with the presence of chromosome 14 in human-mouse hybrid cells.
    Yamamoto K; Mizuno F; Matsuo T; Tanaka A; Nonoyama M; Osato T
    Proc Natl Acad Sci U S A; 1978 Oct; 75(10):5155-9. PubMed ID: 217014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new lymphoid cell line, Reh 6, with characteristics of non-T and non-B cells, lacking the Epstein-Barr virus genome and derived from human acute lymphoblastic leukemia.
    Kayibanda B; Rosenfeld C; Goutner A; Bornkamm GW
    Intervirology; 1978; 9(5):316-20. PubMed ID: 202576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EBV-activation of human B-lymphocytes.
    Aman P; Lewin N; Nordström M; Klein G
    Curr Top Microbiol Immunol; 1986; 132():266-71. PubMed ID: 3024919
    [No Abstract]   [Full Text] [Related]  

  • 12. Establishment of a new Epstein-Barr virus nuclear antigen-positive B-cell line, BALL-2, with t(8;14) (q24;q32) chromosome abnormality from B-cell acute lymphoblastic leukemia, L2.
    Kubonishi I; Daibata M; Yano S; Isobe M; Kurosawa N; Nagumo H; Ogita Z; Ohyashiki JH; Toyama K; Miyoshi I
    Am J Hematol; 1991 Jul; 37(3):179-85. PubMed ID: 1650133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of an Epstein-Barr virus-determined nuclear antigen-negative human B-cell line from acute lymphoblastic leukemia.
    Hiraki S; Miyoshi I; Masuji H; Kubonishi I; Matsuda Y
    J Natl Cancer Inst; 1977 Jul; 59(1):93-4. PubMed ID: 195075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early events in Epstein-Barr virus infection provide a model for B cell activation.
    Thorley-Lawson DA; Mann KP
    J Exp Med; 1985 Jul; 162(1):45-59. PubMed ID: 2989413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B cell activation and the establishment of Epstein-Barr virus latency.
    Hurley EA; Thorley-Lawson DA
    J Exp Med; 1988 Dec; 168(6):2059-75. PubMed ID: 2848918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus transforms precursor B cells even before immunoglobulin gene rearrangements.
    Katamine S; Otsu M; Tada K; Tsuchiya S; Sato T; Ishida N; Honjo T; Ono Y
    Nature; 1984 May 24-30; 309(5966):369-72. PubMed ID: 6328311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment and characterization of a new Epstein-Barr virus transformed cell line from a human B cell lymphoma.
    Janssen O; Heinze B; Bartram CR; Pawlita M; Binder T; Heimpel H; Diehl K; Kabelitz D
    Blut; 1990 Mar; 60(3):206-12. PubMed ID: 2156585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transformation of lymphocytes by Epstein-Barr virus requires only one-fourth of the viral genome.
    Mark W; Sugden B
    Virology; 1982 Oct; 122(2):431-43. PubMed ID: 6293180
    [No Abstract]   [Full Text] [Related]  

  • 19. Direct outgrowth of in vivo Epstein-Barr virus (EBV)-infected chronic lymphocytic leukemia (CLL) cells into permanent lines.
    Lewin N; Aman P; Mellstedt H; Zech L; Klein G
    Int J Cancer; 1988 Jun; 41(6):892-5. PubMed ID: 2836321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and characterization of adult T-cell leukemia virus-containing B-cell lines derived from peripheral blood of adult T-cell leukemia patients.
    Miyamoto K; Tomita N; Ishii A; Nishizaki T; Togawa A
    Gan; 1984 Aug; 75(8):655-9. PubMed ID: 6092185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.